According to the American Cancer Society, the number of colorectal cancers in the US for 2024 are estimated to be about 106,590 new cases of colon cancer (54,210 in men and 52,380 in women) and about 46,220 new cases of rectal cancer (27,330 in men and 18,890 in women).
Tag: fecal immunochemical test (FIT)
Patients with higher fecal hemoglobin concentration at FIT may benefit from shorter CRC screening intervals
Stratifying colorectal cancer (CRC) risk based on hemoglobin concentration at fecal immunochemical test, or FIT, could help to determine whether patients could benefit from shorter screening intervals. A brief research report is published in Annals of Internal Medicine.